MGYOY yields 6.22% · PFE yields 6.13%● Live data
📍 MGYOY pulled ahead of the other in Year 1
Combined, MGYOY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MGYOY + PFE for your $10,000?
MOL Magyar Olaj- és Gázipari Nyilvánosan Muködo Részvénytársaság, together with its subsidiaries, operates as an integrated oil and gas company in Hungary and internationally. It operates through five segments: Upstream, Downstream, Consumer Services, Gas Midstream, and Corporate and Other. The company is involved in the refining, transportation, and storage of crude oil; wholesale and retail of crude oil products; geothermal energy production; natural gas transmission; feed water and raw water supply; water transportation; refinery and marketing of oil and petrochemical products; importing and exporting of energetical products; warehousing and oil product storage activities; and exploration and production of crude oil, natural gas, and other gas products. It also engages in the provision of transportation, fleet management, and financial services; marketing agency activities; production and distribution of electricity; production and retail trade of lubricants; and retail and wholesale trade of fuels. In addition, the company provides business, accounting, IT, and company services; construction and engineering, pipeline construction, and leasing activities; repair and maintenance services; investment management services; and real estate management services, as well as manufactures and sells machinery and equipment. Further, it engages in the mineral water production and distribution activities; exploration of hydrocarbon; provision of exploration financing, car sharing, firefighting, tourism, oilfield, and rental services; petrochemicals and consumer retail activities, as well as provision of fire, hospitality, and catering services; and operation of café houses. The company was incorporated in 1991 and is headquartered in Budapest, Hungary.
Full MGYOY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.